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Background: The strongest risk factor for depression is having a family history of the condition. Many individuals with
a family history of depression are concerned about their personal risk for depression and report unmet educational and
psychological support needs. No supportive and/or educational interventions are currently available that target this
group of individuals. In this study we will develop and evaluate the first online psycho-educational intervention
targeted to individuals with a family history of depression. Genetic risk information and evidence-rated information
on preventive strategies for depression will be provided to such individuals in a general practice setting. The
intervention will also incorporate a risk assessment tool. The content and delivery of the intervention will be
pilot-tested.
Methods/design: The proposed intervention will be evaluated in the general practitioner (GPs) setting, using a
cluster randomized controlled trial. GP practices will be randomized to provide either access to the online,
targeted psycho-educational intervention or brief generic information about depression (control) to eligible patients.
Eligibility criteria include having at least one first-degree relative with either major depressive disorder (MDD) or bipolar
disorder (BD). The primary outcome measure is ‘intention to adopt, or actual adoption of, risk-reducing strategies’.
Secondary outcome measures include: depression symptoms, perceived stigma of depression, knowledge of risk
factors for development of depression and risk-reducing strategies, and perceived risk of developing depression
or having a recurrence of family history. Over the course of the study, participants will complete online questionnaires
at three time points: at baseline, and two weeks and six months after receiving the intervention or control condition.
Discussion: This novel psycho-educational intervention will provide individuals with a family history of depression with
information on evidence-based strategies for the prevention of depression, thus, we hypothesize, enabling them to
make appropriate lifestyle choices and implement behaviors designed to reduce their risk for depression. The online
psycho-educational intervention will also provide a model for similar interventions aimed at individuals at increased
familial risk for other psychiatric disorders.
Trial registration: The study is registered with the Australian and New Zealand Clinical Trials Group
(Registration no: ACTRN12613000402741).
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Having a family history of depression is the strongest
documented risk factor for depression [1]. Family, twin,
and adoption studies strongly suggest that both major
depressive disorder (MDD) and bipolar disorder (BD)
have heritable components [2], with heritability esti-
mates of 40% for MDD [1,3] and 80% for BD [4,5].
A meta-analysis of family studies of MDD found a
relative risk of 2.8 for MDD in first-degree relatives of
affected probands, compared to control subjects [1],
which is greater than all other reported risk factors. The
presence of multiple relatives with MDD, as well as early
age of onset, recurrence and severity of the depression
in affected relatives, are factors that indicate an even
higher familial risk [6]. The magnitude of familial aggrega-
tion for BD is extremely high; the relative risk in first-
degree relatives of probands with BD compared to control
cases has been estimated at 13.6 [7].
Genes that are responsible for an inherited susceptibil-
ity to depression are still the focus of intensive research
efforts; genetic testing for susceptibility to mental health
conditions is not available for clinical use. Given this,
family history is currently the best predictor for the devel-
opment of MDD and BD [6]. The role of family history as
a key risk factor is undisputed, and epidemiological data
can be used to provide people with a family history with
estimates of their risk.
Many individuals with a family history of depression
report unmet educational and psychological support
needs in relation to a range of issues, including: estimat-
ing their personal risk of developing depression, as well
as the risk to offspring; learning how depression can be
prevented in those at increased risk based on family
history, as well as early intervention and risk modifi-
cation in young relatives; how to cope with family
vulnerability; and reproductive decision-making [8,9].
Despite this well-documented endorsement of the need
for psycho-educational interventions, no such interven-
tions are currently available targeting this group of
individuals.
Virtually nothing is known about the optimal approaches
to providing risk information to people with a family his-
tory of depression. Professional guidelines suggest that
genetic risk information should be offered to people with
BD and their families, particularly those who are consider-
ing having children [10]. The following groups of individ-
uals may benefit from risk information in particular: adult
children, siblings and parents of affected individuals; af-
fected individuals and their partners planning their fam-
ilies; and, affected people who maintain high-risk behaviors
[11]. Indeed, as many as 75% of individuals with BD report
that they would like expert advice about their genetic risk
[12]. The guidelines, however, do not provide guidance on
how to deliver the information.Despite the potential value of information provision
about familial risk, surveys of genetic counselors and
psychiatrists show that they feel ill equipped to provide
patients with such information [13-15]. Estimating the
risks for the development of depression is challenging,
given the lack of systematic reviews and meta-analyses
available on more complex family relationships (e.g. risk
associated with having a second-degree rather than first-
degree relative with depression, presence of multiple af-
fected relatives on either one side only or both sides of
the family), and possible presence of a heterogeneous
group of disorders within a given family.
Finally, further complexity is introduced through the
contribution of environmental factors, which may be either
familial or non-familial. Environmental familial factors per-
tain to the shared familial environment (e.g. parenting
style), and environmental non-familial factors relate to the
known contribution of sociodemographic variables, indi-
vidual environmental (e.g. stressful life events) and health-
related factors (e.g. presence of non-psychiatric chronic
illness). It should, however, be noted that empirical
risks reported by family studies (as distinct from adop-
tion and twin studies) do not allow for a differentiation
between familial genetic and environmental contribu-
tors to depression risk [1].
It is critical that information on familial risk for de-
pression to individuals at increased risk is accompanied
by the provision of advice on early detection, risk man-
agement and prevention. For example, individuals at
increased familial risk should be advised to undergo
regular screening by a health care provider in a timely
manner, to capitalize on the predictive power of early
warning signs and intervene preventively [16], in ac-
cordance with new prevention frameworks in psych-
iatry, which regard minor depression as a risk factor
for MDD [17]. While several risk factors for depres-
sion, including family history, cannot be changed, indi-
viduals at increased risk are likely to benefit from
accurate and up-to-date information on risk factors
that are amenable to change and/or strategies they
may adopt to reduce their risk. Such risk management
strategies may either be based on evidence from random-
ized controlled trails (RCTs) (e.g. cognitive behavioral
therapy [CBT], regular exercise) [18-22] or represent po-
tential risk-reducing strategies that correspond to univer-
sally recognized standards for healthy living (e.g. avoiding
illicit drugs and excessive consumption of alcohol, getting
adequate sleep) [23-25].
Studies of individuals and families with BD suggest
that patients and families often vastly overestimate the
absolute risks of depression development in first-degree
relatives [2,12]. Furthermore, in our previous work in-
volving individuals from families with multiple cases of
MDD and BD, we found that concerns about increased
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children [9,26]. These data are of concern given that re-
luctance to have children may in part be likely based
on overestimations of risks and suggest that psycho-
educational interventions need to address inaccurate
risk perceptions. Our prior work also ascertained the
information needs of families with multiple members
with depression [27]. The majority of people reported
wished to obtain information directly from health pro-
fessionals [27]. However, the need for additional infor-
mation sources was also identified, and videos and
accessing information through the internet were highly
rated options.
While high-quality websites on depression are avail-
able in Australia (e.g. www.beyondblue.org.au, www.
bluepages.anu.edu.au, www.blackdoginstitute.org.au) and
internationally, they are not targeted to people with a fam-
ily history of depression. In this study we will develop a
world-first online, evidence-based psycho-educational
intervention targeting people at increased risk for de-
pression by virtue of their family history. The interven-
tion will offer ‘depression literacy’, including education
on prevention and treatment strategies targeted to
people with a family history of depression; it will not
be designed to provide therapy to prevent or treat de-
pression. The evidence for efficacy of such interven-
tions has been illustrated: several high-quality online
interventions that deliver therapy are already available
(e.g. MoodGYM) [28]. Evidence is also available that
an online intervention focused on depression literacy
(e.g. BluePages) is as effective as online CBT (MoodGYM)
in reducing the symptoms of depression [29].
The identification of people at increased risk for gen-
etic conditions is particularly challenging because of the
unique nature of shared DNA within families, generating
implications for whole families rather than merely the
individuals involved. Thus, family dynamics and commu-
nication patterns can play a major role in determining
how information about genetic risk is shared within the
family and how individual family members make deci-
sions about, for example, reproduction, early detection
and prevention of depression.
Depression with a hereditary component raises several
unique issues which call for a sophisticated and rigor-
ously tested approach to patient education. First, infor-
mation on one’s familial susceptibility to a psychiatric
disorder has the potential to impact on the individual’s
sense of well-being and integrity and, in the most vul-
nerable cases, to precipitate the feared condition [30].
Another feature that is likely to compound the delivery
of psycho-education is the stigma associated with psy-
chiatric disorders [30,31]. In contrast to individuals with
chronic physical conditions, those with psychiatric disor-
ders are amongst the most highly stigmatized groups insociety [32,32], regardless of the degree of genetic con-
tribution. In our prior work we found that endorsement
of a genetic model for depression was strongly correlated
with perceived stigma, which suggests that having a gen-
etic explanation for depression has the potential to fur-
ther exacerbate the stigma associated with this condition
[9]. These data show that a psycho-educational interven-
tion needs to be highly sensitive to the challenges faced
by people at increased hereditary risk for depression; our
intervention, therefore, aims to provide accurate and
realistic information about familial risk without increas-
ing the perceived stigma associated with depression [34].
To address the unique challenges posed by depression
with a hereditary component, this project employs a so-
phisticated analysis of the existing empirical findings on
genetic risk for depression and a complex and rigorous
methodology.
Study objectives and hypotheses
This study aims to evaluate the first online psycho-
educational intervention targeted to individuals with a
family history of depression to provide such individuals
in a general practice setting with genetic risk informa-
tion and evidence-rated information on preventive
strategies for depression. The intervention to be tested
incorporates a risk assessment tool, delivery of educa-
tion targeted to people with a family history of depres-
sion and feedback to general practitioners (GPs) of
individuals’ risk status. It will be evaluated in the GPs
setting using a cluster RCT.
The primary aim of the study is to determine whether
the intervention, compared to the control condition,
leads to both greater intention to adopt, and actual
adoption of, risk reduction strategies for depression in
people at increased familial risk. The secondary aims are
to evaluate whether the intervention will lead to: lower
levels of depression symptoms and perceived stigma,
and better knowledge about genetic and environmental
risk factors for depression and efficacy of risk reduction
strategies.
The study will test the following hypotheses: compared
to a control group of people receiving brief generic in-
formation about depression, people receiving the tar-
geted psycho-educational intervention will be more
likely to: (i) intend to adopt, and actually adopt, risk re-
duction strategies for depression; (ii) have lower levels of
depression; (iii) have lower perceived stigma related to
depression; and (v) possess better knowledge about risk
factors and risk reduction strategies for depression, two
weeks and six months post-intervention.
Design
This cluster RCT will be conducted in a general practice
setting in the state of New South Wales, Australia. The
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[35]. The study design is presented in Figure 1. GP
practices will be randomized to provide either access
to the online targeted psycho-educational intervention
or brief generic information about depression to eli-
gible patients. We decided against an ‘attention placebo’
group (e.g. another depression website not targeted to
people at high risk for depression) as this would lead to
control group participants accessing variable and hetero-
geneous amounts of education. Instead, participants at-
tending a GP randomized to the control group will
receive brief generic information about depression,
produced by beyondblue (national depression net-
work), i.e. ‘Understanding depression’. Randomization
by participating GP practice will be undertaken cen-
trally using a computer-based randomization program.
Thus the unit of randomization will be the GP practice,
not the individual participant. This design will optimize
the use of the intervention and minimize contaminationInvited to participate th
GP – patients are d
depending on the
Potential participants








Participants will have access to the 
intervention (education materials, risk 
assessment and GP report). Results 
from the FHS and Patient Health 
Questionnaire (PHQ9) will populate the 
report that participants will be able to 
print out. Unless indicated otherwise, 
the report will be forwarded to the GP. 
Participants will be given a login to 
access this site at any time. At the end 
of the session they will be reminded 
that the follow-up questionnaire will be 
emailed to them in 2 weeks. 
2 weeks later, a l
part
6 months after re
materials a link to Q3
Figure 1 Study design and flow of participants through study.between participants attending the same GP; if individual
participants rather than GPs were randomized, the ap-
proach of the doctor to controls could change due to the
doctor’s experience with the tool.
Methods
Participants
The study received ethics approval from the institutional
review board of the University of New South Wales (ap-
proval no 10330) and will be conducted in compliance
with the Helsinki Declaration. GP practices will be broadly
sampled to ensure heterogeneity and generalizability; both
metropolitan and rural GPs practices of varying sizes, in-
cluding GPs working independently, will be invited to par-
ticipate. GPs will be identified using an existing GP
database in metropolitan Sydney, Australia; GPs will be
sent letters of invitation and those returning an expression
of interest form will be contacted to arrange a meeting to
discuss the study. GP practices will be offered an AUDrough a letter from the 
irected to a website 
ir randomisation
 are asked to register and 
History Screen (FHS) to 
 eligibility
Control 
Links to ‘Understanding depression’.




ink to Q2 emailed to 
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 emailed to participants
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ing Medical Education points as an acknowledgement of
the time commitments required to participate in the
study. The research team will be personalized academic
detailing for both groups of GPs provided by in the plan-
ning phase of the study, which will include an explanation
of the study materials. All GPs will be visited by the re-
searchers to collect baseline demographic and practice de-
tails and GPs’ written consent to participate in the trial
will be obtained. The research team will continually liaise
with and visit participating GPs to ensure adherence to
the protocol.
The patient sample will include people with a family
history of at least one first-degree relative with MDD or
BD who: (i) are able to give informed consent; (ii) are
proficient readers in English; (iii) are aged between 18
and 75 years; and are deemed fit by their GP to partici-
pate. Patients attending participating GP practices who
meet the eligibility criteria will be invited to the study.
As many GPs do not elicit and systematically record a
family history of depression, patients will be asked to
self-identify as having a first-degree degree relative with
MDD or BD. Both individuals who have had an episode
of MDD or BD, and those who have not, will be eligible
to participate.
Study procedures
Researchers will work with staff at GP practices to gen-
erate random lists of up to 500 patients per practice
who meet eligibility criteria (i) to (iii) above and have
attended the practice in the last two years. GPs will be
asked to screen these randomly selected patients and ex-
clude those who would not be suitable (e.g. cognitive
impairment, severe illness, patients with a psychiatric
disorder that is currently not well controlled); those
deemed suitable will be sent a letter of invitation by
their GP. Potential participants will be blinded to their
intervention assignment in that they will be told that
the study is comparing different types of educational
interventions. There will be two separate secure study
websites, one with the intervention and one with the
control condition. The letter of invitation will direct
interested individuals to the appropriate study website
according to GP randomization. Participants will opt-in
and be asked to provide a current e-mail address; partici-
pants will then receive a unique username and password
that will enable them to access the appropriate website.
Each participant entering the websites (both interven-
tion and control) will complete the Family History
Screen (FHS) [36] to confirm eligibility (in particular
whether they have a first-degree relative with MDD or
BD) and provide the basis for feedback to the partici-
pants and optionally their GP regarding their family his-
tory details (intervention group only), including whetherthey have had an episode of MDD or BD and brief de-
tails regarding their family history. Ineligible individuals
will be thanked and asked to discontinue participation,
while eligible participants will proceed to complete the
baseline questionnaire. The FHS is a valid and reliable
measure of psychiatric family history and has been
shown to have high sensitivity and specificity for depres-
sion [36]. It identifies the status of the biological first-
degree relatives for assessment (pedigree collection) and
screens lifetime history of MDD and/or BD of the par-
ticipant and the biological relatives identified in the
pedigree. The FHS begins with a broadly sensitive intro-
ductory question about the participant and any first-
degree family member to stimulate memory. If the status
of any family members is provided in response to the
first question, an additional five narrower ‘symptom def-
inition’ questions are asked.
Measures
Socio-demographic data
At baseline, data on sex, age, highest level of education
achieved, current marital status and country of birth will
be collected.
Outcome measures to be administered at all time points
Patient health questionnaire depression (PHQ9) The
PHQ9 is a ten-item self-administered validated instru-
ment, which scores each of the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV) criteria for MDD
[37]. It can be used both as a diagnostic measure as well
as a symptom severity measure and assesses depression
symptoms over the past two weeks. It has 4-point Likert
type response options ranging from “Not at all” to
“Every day”; scores range from 0 to 27, with higher
scores indicating higher levels of depression. Depression
levels can be categorized as mild (5 to 9 scores), moder-
ate (10 to 14 scores), moderately severe (15 to 19 scores)
or severe depression (20 to 27).
Perceived devaluation-discrimination This 12-item scale
will be used to assess perceived stigma of depression. It as-
sesses people’s perceptions of what “most other people”
believe regarding the stigma associated with depression, a
key feature of modified labeling theory according to which
perceived devaluation–discrimination should have no im-
pact on social or psychological functioning in people who
have never been officially labelled with mental illness [38].
The measure was selected on the basis of its sound theor-
etical basis and because it has been used mainly among
people being treated for mental illness. Items explored be-
liefs, such as whether a person with bipolar disorder is just
as trustworthy as the average citizen, and whether one
would willingly accept a person with bipolar disorder as a
friend [38]. Four-point Likert-type response scales will be
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agree” [39], and items will be summed and divided by the
total number of items answered, with higher values indi-
cating greater perceived stigma.
Knowledge of risk factors for development of depres-
sion and risk-reducing strategies 10 items have been
purposively designed to assess knowledge of the: (i) genetic
and environmental risk factors for depression development
and (ii) efficacy of a range of prevention strategies that are
covered in the intervention. Item wording is shown in list
below. A score of one will be given for each correct answer
and a score of zero for an incorrect or “don’t know”
response. Total knowledge score will be calculated by
summing the correct responses (range 0–10).
Perceived susceptibility to major depressive disorder
and bipolar disorder Two items adapted from a previ-
ous study [40] will assess: participants’ perceived risk of
“developing (or having a recurrence of ) MDD” and “de-
veloping (or having a recurrence of ) BD” compared to
an “average person of the same age and gender”, using
Likert-scale response options ranging from 1 (“Much
lower”) to 5 (“Much higher”).
Intention to adopt, and actual adopting of, risk-
reducing strategies Eight items will be used to measure
participants’ intention to adopt, and actual adoption of a
range of ‘risk-reducing strategies’ that were covered in the
intervention; only strategies for which at least some evi-
dence of efficacy (prospective data or stronger evidence) is
available will be included in this measure. Response options
include: “No, and I do not intend to in the next six months”
(0), “No, but I intend to in the next six months” (1), “No,
but I intend to in the next 30 days (2)”, and “Yes, I have
been, but for less than six months” (3), and “Yes, I have
been for more than six months” (4). Scores for each item
represent the five stages of change: Pre-contemplation (0),
Contemplation (1), Preparation (2), Action (3), and Main-
tenance (4) [41,42]. For analyses, a total mean score will be
calculated (range 0 to 4) to assess individuals’ intention and
actual adopting of risk-reducing strategies. In addition, for
each strategy where participants indicated “Yes”, they will
also be asked “how successful they have been” in imple-
menting the strategy. Four-point Likert-type response
options will be used, ranging from "Slightly successful" to
"Completely successful".
Knowledge of risk factors for development of
depression and risk-reduction strategies
Environmental factors count for about 40% of
developing major depressive disorder. (False)
Genetic factors count for about 80% of developing
bipolar disorder. (True)Having a family history of depression means that a
person will definitely get depression. (False)
Chronic stress or having a disability or long-term health
condition can increase one’s chances of developing
depression. (True)
Being female and drug misuse both can decrease the
chance of developing depression. (False)
Parental style does not appear to increase chance of
developing depression in people with a family history of
depression. (True)
Psychological therapies are very effective in preventing
the development of depression. (True)
Regular exercise is definitely not effective in preventing
the development of depression. (False)
Lifestyle behaviors such as getting enough sleep, eating
a Mediterranean diet, and getting enough vitamin D
are definitely not effective in preventing the
development of depression. (False)
Having a positive attitude, good social support and
greater spiritual well-being may be effective in
preventing the development of depression. (True)
Intention to adopt, and actual adoption of,
risk-reduction strategies
We would like to know whether you would make
changes to your lifestyle to reduce your chance of
developing depression. Please indicate from the list
below how likely you would be to undertake these
risk-reducing strategies. Have you...
…used psychological therapy to reduce your chance of
developing depression?
…been exercising at a moderate-intensity for 30 minutes of
each day to reduce your chance of developing depression?
…been getting adequate amounts of sleep (7-9 hours of
sleep each day) to reduce your chance of developing
depression?
…been eating a Mediterranean-style diet (rich in
vegetables, fruits, nuts, whole grains and fish) to
reduce your chance of developing depression?
…been getting the recommended daily intake of
vitamin D (either from the spending time in the sun or
through food and supplements) to reduce your chance
of developing depression?
…been getting good social support to reduce your
chance of developing depression?
…been maintaining a positive attitude towards most
things to reduce your chance of developing depression?
…joined a religious group or developed your spirituality
to reduce your chance of developing depression?
Intervention
Following completion of the baseline questionnaire, inter-
vention group participants will be directed to the interven-
tion, which is entitled ‘Understanding depression that runs
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family history assessment and screening test for depression
symptoms; (ii) psycho-educational materials, which will be
presented in the form of screens containing written infor-
mation, illustrations and photos; (iii) short video clips,
featuring two experts in depression and actors, which will
supplement the information covered in the written text;
and (iv) an interactive component where participants will
be asked to rank the risk-reducing strategies they would like
to implement. Upon entry, the results from the family his-
tory risk assessment and the screening test for depression
(PHQ9) will be fed back to both the participant and, if the
participant opts to share the results with their GP, to the
GP, in the form of a one page report. Feedback to the GP
will via e-mail or fax, according to the GP’s preference, for
inclusion in the patient’s file; or the participant may opt to
provide the GP with a paper copy of his/her results. The
printable or viewable feedback will include details on the
participant’s family history as ascertained by the Family
History Screen and one of five depression screening feed-
back reports, with different recommendations depending
on the participant’s depression severity category: do noth-
ing, or recommendations regarding follow-up screening,
treatment plan, initiation of treatment and/or referral to a
mental health specialist [43]. The intervention was devel-
oped using an iterative process involving a multidisciplin-
ary team, including one consumer representative. The
development and pilot-testing of the intervention will be
reported separately in detail. The content and format of
the intervention was based on the information preferences
expressed in a previous qualitative study of 23 people with
a family history of MDD [Quinn V*, Meiser B*, Wilde A,
Cousins Z, Barlow-Stewart K, Mitchell P, Schofield P:
Preferences regarding targeted education and risk assess-
ment in people with a family history of major depressive
disorder *joint first authors, submitted], where most par-
ticipants reported being interested in accessing depression
information via the internet. Also, while we recognize that
a web-based tool excludes those without Internet access,
it is the best means of reaching the largest numbers of in-
dividuals at a very low cost. It can also be readily updated
as evidence accumulates in this rapidly developing field of
genetics and depression.
The intervention meets the Medical Research Council’s
(UK) criteria of a complex intervention (www.mrc.ac.uk/
complexinterventionsguidance); the Medical Research
Council’s conceptual framework guides the development
and testing of the intervention. The intervention was devel-
oped to be completed in either one only session or several
sessions. Some of the intervention content is more relevant
to participants who have never had MDD or BD (e.g. the
sections about the risk estimates of developing depression
based on family history), while other sections may be more
relevant to those have had an episode of MDD or BD (e.g.sections on likelihood of recurrence). However, the inter-
vention was designed for participants to navigate website
content based on their personal preference. In brief, the
psycho-educational intervention includes sections on: gen-
etic and individual and shared environmental factors;
differences in genetic information and depression risk; esti-
mating one’s risk of depression development based on fam-
ily history; risk factors for recurrence of depression; role of
environmental factors, including stressful life events, in
determining depression risk; strategies to reduce and/or
prevent depression development; childbearing decisions;
suicide risk; stigma in relation to having a family history of
depression; early detection, especially in children and ado-
lescents; and early intervention. The written text of the
online intervention is designed to be printable for those
who would like a paper version of the tool. The sections on
estimating one’s risk of depression development based on
family history are presented using pictographs (also called
icon arrays or “one hundred people” diagrams) to maximize
comprehension [44].
Control
Following completion of the baseline questionnaire, control
group participants will be directed to a PDF of a brief
generic pamphlet on depression produced by beyondblue
(National Depression Network), ‘Understanding depression’,
which includes information about common symptoms of
depression, criteria used to diagnose depression and treat-
ments available. Following completion of the six-month
survey, control group participants will be provided with
access to intervention.
Sample size and statistical power
The primary outcome measure will be ‘intention to adopt
risk-reducing strategies’; on the basis of our quantitative
survey of a large nationally representative population
sample of 1,046 Australian participants, we expect a mean
baseline percentage of 50% of people intending to adopt a
range of risk-reducing strategies [45]. Behavioral intentions
were chosen as the primary outcome variable to gain an
understanding of the issues related to this topic and while
behavioral intentions are only an indirect measure of actual
behavior, at present they are the best single predictor of
future behavior in the psychological literature [46,47].
According to as yet unpublished data from the 2010
National Survey of Mental Health and Wellbeing, at least
20% of Australian residents have at least one first-degree
relative with either MDD or BD. Based on similar work
involving the testing of a cancer family history assessment
tool, it is estimated that approximately 15% of patients will
opt-in to an online trial following an invitation letter from
their GP [48]. By contacting up to 500 patients for each GP
practice, we expect to recruit up to 15 participants per
practice.
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ation coefficient (ICC) of 0.06 for patients within the same
practice, consistent with ICCs observed for psychological
problems in patient encounters in Australian general
practice [49]. Assuming an average of twelve participants
within each practice, randomizing a total of 20 GP practices
will provide 80% power to detect a difference of 22% in the
proportion intending to undertake risk-reducing strategies
from a control proportion of 50%. This difference, corre-
sponding to a medium effect size [50], is based on the smal-
lest effect that would have clear public health significance
and provides a sensitive indicator of clinically meaningful
differences.
Statistical methods
Analysis for the dichotomous primary outcome, intention
to adopt risk-reducing strategies, will be performed using
the generalized linear mixed model, which extends the
standard logistic regression model to allow for clustered
data. The continuous outcome of PHQ9 will be analyzed
using the linear mixed model. Adjustment for any potential
confounding variables (such as age, sex, type of family his-
tory) will be made if there is important baseline imbalance
in these variables between intervention groups.
Discussion
MDD is predicted to contribute the second most disabling
largest burden of disease worldwide by 2030 [51]. Given the
current climate of cost constraints, a strong need exists to
selectively target initiatives to prevent the development of
depression in individuals at increased familial risk. The rela-
tive risk for depression is substantially increased in close
biological relatives of people with MDD and BD. Thus
many individuals with a family history of depression are
concerned about their personal risk and that of their off-
spring and report unmet psycho-educational needs on how
psychiatric risk can be modified and what steps can be
taken to prevent depression.
Currently no research is available on the efficacy of
psycho-educational resources specifically aimed at people
who are at increased risk of depression due to their family
history, despite evidence that such individuals have many
unmet information needs. If proven effective, the interven-
tion can be readily adapted to other contexts, for example,
as a stand-alone tool or a communication aid to supple-
ment consultations provided by psychiatrists and genetics
health professionals to people at increased familial risk for
depression. The online psycho-educational intervention will
also provide a model for similar interventions aimed at
individuals at increased genetic risk for other psychiatric
disorders.
An innovative online psycho-educational intervention
has been developed, which will be rigorously evaluated to
provide individuals at elevated risk in a general practicesetting with genetic risk information and evidence-rated
information on preventive strategies for depression. A
core recommendation of recent governmental policies
internationally is the role of primary care in identifying
high-risk populations for a wide range of chronic diseases
and the promotion of targeted, evidence-based interven-
tions for disease prevention [29]. Primary care is an ideal
setting for the identification of people at increased familial
risk for psychiatric disorders and a natural setting for
implementing preventive strategies. Family history is an
important risk factor for many chronic diseases, and
family history assessment tools have been developed and
evaluated in the general practice setting to identify people
with a family history of chronic disease, including breast,
ovarian and/or colorectal cancer and/or ischemic heart
disease [52]. To our knowledge no tools are currently
available for use in the general practice setting to identify
people with a family history of psychiatric disorders,
including depression, although such tools have been
developed for the research setting, e.g. the Family History
Screen [36]. Family history assessment tools for other
chronic diseases cannot be used to provide a model for
interventions for individuals at increased familial risk for
psychiatric disorders, including depression, due to the
unique nature of these disorders.
The intervention to be tested will provide individuals
at increased risk with information on evidence-based
strategies for the prevention of depression, thus enabling
them to make appropriate lifestyle choices and implement
behaviors designed to reduce their risk for depression
development. It is anticipated that the novel intervention
targeting individuals at increased familial risk will lead to
a better understanding of the broad associated genetic
risks of depression, increased use of risk-reduction strat-
egies, lower psychological distress and perceived stigma,
greater consumer satisfaction, and increased motivation to
adopt preventative strategies to reduce the risk for
depression.Abbreviations
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